India to Netherlands: Glibenclamide Export Trade Route

The India to Netherlands Glibenclamide corridor is one of India's established pharmaceutical export routes, with 24 shipments documented worth a combined $208.7K USD. The route is dominated by MEDOPHARM , which alone accounts for roughly 71% of all export value, reflecting the consolidated nature of India's glibenclamide manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $8.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with glibenclamide's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 25.1%, placing it at rank #6 among India's top glibenclamide export destinations globally.

On the import side, key buyers of Indian glibenclamide in Netherlands include M/S. IMRES , IMRES, TO THE ORDER and 6 others. M/S. IMRES is the single largest importer with 10 shipments valued at $142.4K USD.

India's glibenclamide exports to Netherlands are driven primarily by a handful of large-scale manufacturers. MEDOPHARM with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Netherlands benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDOPHARM , MEDOPHARM, S KANT HEALTHCARE LIMITED — together account for 94% of total trade value on this route. The average shipment value of $8.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as glibenclamide tablets bp 5mg (50000 x 10 and glibenclamide tablets bp 5mg (60000 x 10 , suggesting that buyers in Netherlands tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, M/S. IMRES is the largest importer with 10 shipments worth $142.4K USD — representing 68% of all glibenclamide imports from India on this route. A total of 9 buyers are active on this corridor.